| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 07/22/2009 | EP1391456B1 2-iminoimidazole derivatives |
| 07/22/2009 | EP1379224B1 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 07/22/2009 | EP1263719B1 N-deacetylthiocolchine derivatives and pharmaceutical compositions containing them |
| 07/22/2009 | EP1220922B1 Method of identifying a compound with efficacy in the treatment of chronic inflammatory diseases |
| 07/22/2009 | EP1133517B1 INTRANUCLEAR TARGETED DELIVERY OF COMPOUNDS BY 70 kD HEAT SHOCK PROTEIN |
| 07/22/2009 | EP1115390B1 Hydroxamate-containing cysteine and serine protease inhibitors |
| 07/22/2009 | CN101486682A N3 alkylated benzimidazole derivatives as MEK inhibitors |
| 07/22/2009 | CN100516220C Serine proteinase inhibitor of bifidobacteria |
| 07/22/2009 | CN100516037C Nitrooxyderivatives of cyclooxygenase-2 inhibitors |
| 07/22/2009 | CN100516024C Amino-propanol derivatives |
| 07/22/2009 | CN100515497C Liposomal delivery of vitamin E based compounds |
| 07/22/2009 | CN100515422C Composition containing benzamidine derivative and method for stabilizing benzamidine derivative |
| 07/21/2009 | US7563872 Gene coding, gene expression, purification; used as detergents, cosmetics, leather processing, softening for food, meats, animal feeds |
| 07/21/2009 | US7563809 Nociceptin analogs |
| 07/21/2009 | US7563790 Pyridazine derivatives |
| 07/21/2009 | US7563784 substituted 1,1,4-1l6-trioxo[1,2]thiazepan-4-ylamide-derived protease inhibitors which inhibit the likes of cathepsin K; treating osteoporosis, osteo- and rheumatoid arthritis and periodontal disease; inhibiting excessive cartilage or matrix degradation |
| 07/21/2009 | US7563765 Histidine-rich glycoprotein |
| 07/21/2009 | US7563760 P-selectin ligand protein |
| 07/21/2009 | US7563586 Tetrodotoxin resistant membrane protein for use in pain management |
| 07/21/2009 | US7563582 Identifying chemical compounds which are capable of modulating the interaction between vasodilator-stimulated phosphoprotein and zyxin |
| 07/21/2009 | US7563458 Nutritional compositions for nutritional management of patients with liver disease |
| 07/21/2009 | CA2514750C Methods and compositions utilizing astaxanthin |
| 07/21/2009 | CA2470809C 6-amino-morphinan derivatives, method of manufacturing them and their application |
| 07/21/2009 | CA2387486C Use of dipyridamole or mopidamol in the manufacture of a medicament for the treatment and prevention of fibrin-dependent microcirculation disorders |
| 07/21/2009 | CA2382098C Sustained-release, oral pharmaceutical forms of administration |
| 07/21/2009 | CA2379972C Prodrug of an ice inhibitor |
| 07/16/2009 | WO2009089132A1 Substituted-aryl-2-phenylethyl-1h-imidazole compounds as subtype selective modulators of alpha 2b and/or alpha 2c adrenergic receptors |
| 07/16/2009 | WO2009089083A1 Trpa1 antagonists |
| 07/16/2009 | WO2009089082A1 Trpa1 antagonists |
| 07/16/2009 | WO2009088931A1 Method of selecting soybeans with enhanced bioactivity and compositions for reducing cancer cell viability |
| 07/16/2009 | WO2009088849A2 Treatment or prevention of inflammation by targeting cyclin d1 |
| 07/16/2009 | WO2009088065A1 HUMANIZED ANTI-HUMAN α9-INTEGRIN ANTIBODY |
| 07/16/2009 | WO2009088064A1 IMPROVED HUMANIZED ANTI-HUMAN α9-INTEGRIN ANTIBODY |
| 07/16/2009 | WO2009088063A1 Pharmaceutical composition, use of 2-iminopyrrolidine derivative for production of pharmaceutical composition, and kit for treatment or amelioration of heart diseases |
| 07/16/2009 | WO2009087285A1 5,6-diaryl pyridines substituted in the 2- and 3-position, preparation thereof and therapeutic use thereof |
| 07/16/2009 | WO2009065946A3 Pharmaceutical kit consisting of an oil-in-water emulsion and a solid composition |
| 07/16/2009 | WO2008149354A3 Agents for the treatment of inflammatory diseases and methods of using same |
| 07/16/2009 | WO2008147562A3 Dietary formulations and methods for treatment of inflammation and other disorders |
| 07/16/2009 | WO2008132458A8 Compositions useful in the modulation of immune responses and the treatment or prevention of inflammatory responses and related methods |
| 07/16/2009 | WO2008114037A8 Treatment of inflammation and/or endotoxic shock |
| 07/16/2009 | WO2008094942A8 Humanized antibodies against cxcr3 |
| 07/16/2009 | WO2008068171A9 Substituted pyrimidines and their use as jnk modulators |
| 07/16/2009 | US20090182143 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 07/16/2009 | US20090182027 Methods of using [3.2.0] heterocyclic compounds and analogs thereof |
| 07/16/2009 | US20090181989 Purine Compunds as HSP90 Protein Inhibitors for the Treatment of Cancer |
| 07/16/2009 | US20090181985 IMIDAZO[1,2-b]PYRIDAZINE COMPOUND |
| 07/16/2009 | US20090181982 Substituted pyrroline kinase inhibitors |
| 07/16/2009 | US20090181968 Novel 3-Bicyclocarbonylaminopyridine-2-Carboxamides or 3-Bicyclocarbonylaminopyrazine-2-Carboxamides |
| 07/16/2009 | US20090181962 Substituted thiophene compounds |
| 07/16/2009 | US20090181959 HETEROARYL SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AND PYRROLO[2,3-b]PYRIMIDINES AS JANUS KINASE INHIBITORS |
| 07/16/2009 | US20090181957 Benzimidazolone derivatives as cb2 receptor ligands |
| 07/16/2009 | US20090181950 Histamine Receptor Antagonists Comprising an Azepin Core |
| 07/16/2009 | US20090181949 1h-imidazole derivative having cb1, agonistic, cb1 partial agonistic or cb1 antagnistic activity |
| 07/16/2009 | US20090181946 Benzaepinones as Sodium Channel Blockers |
| 07/16/2009 | US20090181943 Inhibitors of Histone Deacetylase |
| 07/16/2009 | US20090181940 Imidazopyrazine Tyrosine Kinase Inhibitors |
| 07/16/2009 | US20090181897 Cxcr4 antagonist and use thereof |
| 07/16/2009 | US20090181882 Methods and preparations for curing critically ill patients |
| 07/16/2009 | US20090181100 Dry powder aerosols of Nanoparticulate drugs |
| 07/16/2009 | US20090181081 Systemic Treatment of Pathological Conditions Resulting From Oxidative Stress and/or Redox Imbalance |
| 07/16/2009 | US20090181069 Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom |
| 07/16/2009 | US20090180996 Epigenetic modification of cell phenotype, fate and/or function by RNA transfer |
| 07/16/2009 | US20090180951 Inhibitors of integrin vla-4 |
| 07/16/2009 | CA2794054A1 Proline analogs as ligands for cannabinoid receptors |
| 07/16/2009 | CA2711882A1 Improved humanized anti-human .alpha.9-integrin antibody |
| 07/16/2009 | CA2711840A1 Formulations for the treatment of mucositis induced by antitumor or immunosuppressive therapy |
| 07/16/2009 | CA2711612A1 Pharmaceutical composition, use of 2-iminopyrrolidine derivative for production of pharmaceutical composition, and kit for treatment or amelioration of heart diseases |
| 07/16/2009 | CA2711508A1 Proline analogs as ligands for cannabinoid receptors |
| 07/16/2009 | CA2711464A1 Substituted-aryl-2-phenylethyl-1h-imidazole compounds as subtype selective modulators of alpha 2b and/or alpha 2c adrenergic receptors |
| 07/16/2009 | CA2711408A1 Trpa1 antagonists |
| 07/16/2009 | CA2711159A1 Trpa1 antagonists |
| 07/16/2009 | CA2710022A1 Method of selecting soybeans with enhanced bioactivity and compositions for reducing cancer cell viability |
| 07/16/2009 | CA2706028A1 Composition comprising a nitrooxyderivative of acetaminophen and a anticonvulsant drug for the treatment of neuropathic pain |
| 07/16/2009 | CA2702012A1 5,6-diaryl pyridines substituted in the 2- and 3-position, preparation thereof and therapeutic use thereof |
| 07/15/2009 | EP2078718A1 N-aryl diazaspiracyclic compounds and methods of preparation and use thereof |
| 07/15/2009 | EP2078711A1 (Aza)indole derivative substituted in position 5, pharmaceutical composition comprising it, intermediate compounds and preparation process therefor |
| 07/15/2009 | EP2078021A2 Pyrazolopyrimidine analogs and their use as mtor kinase and pi3 kinase inhibitors |
| 07/15/2009 | EP2078018A1 Heteroaryl compounds, compositions thereof, and use thereof as protein kinase inhibitors |
| 07/15/2009 | EP2078015A2 Modulators of glucocorticoid receptor, ap-1 and/or nf-kappab activity and use thereof |
| 07/15/2009 | EP2078012A2 Thrombin receptor antagonists based on the modified tricyclic unit of himbacine |
| 07/15/2009 | EP2077999A1 Hydroxamates as inhibitors of histone deacetylase |
| 07/15/2009 | EP2077998A1 Phthalazine, aza- and diaza-phthalazine compounds and methods of use |
| 07/15/2009 | EP2077834A2 Formulations of phospholipase enzyme inhibitors |
| 07/15/2009 | EP1996603B1 Lipid a antagonists with anti-septic shock, anti-inflammatory, anti-ischemia and analgesic activity |
| 07/15/2009 | EP1844039B1 5-substituted quinoline and isoquinoline derivatives, a method for the production thereof and their use as antiphlogistics |
| 07/15/2009 | EP1752162B1 Collagen-polyvinylpyrrolidone for the treatment of osteoarthritis |
| 07/15/2009 | EP1529037B1 Synthesis of 2-alkylcysteines, 2-(hydroxylated phenyl)-4-alkylthiazoline-4-carboxylic acids and derivatives thereof |
| 07/15/2009 | EP1268802B1 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 07/15/2009 | CN101481359A Cyclic protein tyrosine kinase inhibitors |
| 07/15/2009 | CN100513416C Compounds useful in the manufacture of an anti-inflammatory androstane derivative |
| 07/15/2009 | CN100513392C Novel heteroaryl-substituted acetone derivatives as inhibitors of phospholipase A2 |
| 07/15/2009 | CN100513386C Amide for inhibition of IL-8-induced chemiotaxis of neutrophil leucocytes |
| 07/15/2009 | CN100512832C Medication for treating ache |
| 07/15/2009 | CN100512811C Hepatoprotective activity of 10-o-p-hydroxybenzoyiaucubin |
| 07/15/2009 | CN100512809C Compounds and methods of treating transplant rejection |
| 07/14/2009 | US7560591 Benzamidine derivatives having anti-inflammatory and immunosuppressive activity |
| 07/14/2009 | US7560586 Acid and ester compounds and methods of using the same |
| 07/14/2009 | US7560569 (2S,4S)-1-[[(4-carbamoylbicyclo[2.2.2]oct-1-yl)amino]acetyl]-4-fluoropyrrolidine-2-carbonitrile, for treating type II diabetes; increase glucagon-like peptide activity |
| 07/14/2009 | US7560548 antiinflammatory agent N-{[(2S)-4-(3,4-dichlorobenzyl)morpholin-2-yl]methyl}cyclopropane carboxamide; bronchitis, asthma, chronic obstructive pulmonary disease and rhinitis |
| 07/14/2009 | US7560532 Smad6 and uses thereof |